Cancer News and Research

Latest Cancer News and Research

Study identifies factors that increase bankruptcy risk among people with common cancers

An analysis linking federal bankruptcy court records to cancer registry data from nearly 232,000 adult cancer cases in western Washington during a 14-year period has found a hidden cost to survival: Insolvency rates increase along with the length of survival.

8 Jun 2011

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two studies of VELCADE (bortezomib) for Injection based combinations in patients with relapsed or refractory multiple myeloma (MM).

8 Jun 2011

Self-assembling mini devices now enlisted in nanomedicine revolution

Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform for combining targeting and imaging agents, and enabling membrane barriers to be crossed as well as making drug and imaging agent combination therapies possible.

8 Jun 2011

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.

8 Jun 2011

HCRL's Ozioma online tool offers health information through media

Ozioma is a new online tool from the Health Communication Research Laboratory (HCRL) at Washington University in St. Louis designed to increase the amount of locally relevant health information in communities through media.

8 Jun 2011

Doctors place greater value on life-prolonging treatments rather than on quality-enhancing ones

Doctors are more apt to recommend a more costly therapy to patients if it were determined to prolong the patient's life rather than just improve quality, according to a recent study from Medical Decision Making (published by SAGE).

8 Jun 2011

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results from its randomised, double-blind, placebo-controlled Phase IIb clinical trial COMPONENT in RA.

8 Jun 2011

Cabozantinib shows early promise in treatment of prostate cancer spread to the bone

A new drug to treat prostate cancer shows early promise, particularly against tumors that have spread to the bone, a multi-site study shows.

8 Jun 2011

APHON releases position paper on use of social media in workplace

APHON, the Association of Pediatric Hematology/Oncology Nurses, has released a position paper on the use of social media in the workplace, providing guidelines to nurses working with pediatric patients in the hematology and oncology arenas.

8 Jun 2011

Mother's blueberry consumption can improve mammary gland health in offspring

U.S. Department of Agriculture (USDA)-funded studies of mammary gland development in laboratory rats fed blueberries or other foods of interest may aid breast cancer research.

8 Jun 2011

Bio-Nucleonics resumes production of metastatic cancer drug, Strontium-89

Bio-Nucleonics, Inc., a life sciences Company, specializing in the development and manufacture of radiopharmaceuticals, medical devices and imaging agents, will be attending the Society of Nuclear Medicine (SNM) Annual Meeting, held in San Antonio, TX, June 4th through 8th, 2011.

8 Jun 2011

As health care technology advances, costs increase

The device industry has launched an aggressive campaign to avoid tighter Food and Drug Administration rules that would help generate the information needed to show whether newer devices are actually superior to the ones they replace.

8 Jun 2011

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

Edison Pharmaceuticals, Inc. announced today the United States Food and Drug Administration has granted orphan drug designation to EPI-743 for treatment of inherited mitochondrial respiratory chain diseases.

8 Jun 2011

Hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment

Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

8 Jun 2011

Viewpoints: Confronting 'giant' Medicare choices; first lady's anti-obesity campaign; Calif. insurance rules

Sometimes life presents you with a basic philosophical choice. Americans are going to have to confront a giant one over the next several years. It starts in the wonky world of Medicare. ... Democrats have much greater faith in centralized expertise. ... [Republicans] have much greater faith in the decentralized discovery process of the market.

8 Jun 2011

$Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS$

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.

8 Jun 2011

Clinical-research expert moving to Stanford

Steven Goodman, MD, PhD, has worn many hats through his long and varied career, from pediatrician to biostatistician, from epidemiologist to clinical trial expert, from scientist to, well, opera singer. Admittedly, opera has been more of a hobby for him than a career path, but it does give some indication of his ability to master a wide range of subjects.

7 Jun 2011

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.

7 Jun 2011

Smoking increases woman's risk for peripheral artery disease 10-fold

A prospective study of initially healthy women aged 45 and over found that smoking is a potent risk factor for symptomatic peripheral artery disease, or PAD. PAD is a serious, often debilitating disorder, caused by narrowing of the arteries in the lower extremities. Symptoms of PAD include pain in the legs with normal activity and a feeling of tiredness in the leg muscles.

7 Jun 2011

LLS announces four new Academic Concierge partnerships for cancer drug development

With more than 320 academic science research grants currently in its portfolio, The Leukemia & Lymphoma Society (LLS) has made it a priority to help move promising discoveries more quickly from the laboratory to clinical trial and to patients with cancer.

7 Jun 2011

Cancer News and Research

Latest Cancer News and Research

Study identifies factors that increase bankruptcy risk among people with common cancers

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Self-assembling mini devices now enlisted in nanomedicine revolution

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

HCRL's Ozioma online tool offers health information through media

Doctors place greater value on life-prolonging treatments rather than on quality-enhancing ones

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Cabozantinib shows early promise in treatment of prostate cancer spread to the bone

APHON releases position paper on use of social media in workplace

Mother's blueberry consumption can improve mammary gland health in offspring

Bio-Nucleonics resumes production of metastatic cancer drug, Strontium-89

As health care technology advances, costs increase

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

Hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment

Viewpoints: Confronting 'giant' Medicare choices; first lady's anti-obesity campaign; Calif. insurance rules

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Clinical-research expert moving to Stanford

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Smoking increases woman's risk for peripheral artery disease 10-fold

LLS announces four new Academic Concierge partnerships for cancer drug development

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in